Despite some knock-out successes and world-class research, Seattle’s biotechnology industry has remained relatively small compared to other hubs around the country. One of the biggest challenges for the region is… Read More

Accelerator Life Science Partners, a Seattle-based life sciences investment fund and umbrella company, unveiled its newest company with a bang Friday. Proniras Corporation was created to develop the seizure drug tezampanel,… Read More

Stealth-mode startup Taproot Medical Technologies has raised $1.25 million out of a $2.25 million round of funding, according to a filing with the Securities and Exchange Commission. The round is… Read More

Amid all the hype for recreational marijuana use, it’s easy to forget that cannabis and its related plants are also popular for their medicinal effects. Seattle-based RightSciences is taking full… Read More

Klatu Networks has a very niche market: The company makes IoT technology that keeps millions of medical samples and treatments safe from freezer failures. Klatu, which is co-headquartered in the… Read More

When you walk into Juno Therapeutics‘ new headquarters in Seattle, your eyes are immediately drawn to the view. The office’s 12th-floor reception desk offers a stunning panorama of the Olympic mountains,… Read More

Proteins are incredibly important, but incredibly complicated, molecules. They control 98 percent of all biological functions and are used in industries from manufacturing to agriculture. Seattle-based synthetic biology startup Arzeda has… Read More

Genoa Pharmaceuticals — a biopharmaceutical company working on treatments for respiratory diseases — was operating under the radar just last week. But the company sprung into the limelight Monday with a… Read More

Seventeen years after founding the Institute for Systems Biology (ISB), spurring the creation of systems biology as a field, genomics and biotechnology pioneer Lee Hood is stepping down as its… Read More

President Donald Trump released his blueprint for the 2018 federal budget on Thursday. It included deep cuts to a number of science-based departments and organizations, including a 20-percent cut to… Read More

Earth faces some troubling conundrums. On one front, increased levels of carbon dioxide and other gasses are fueling drastic climate change. On another, we’re steadily using up all the planet’s arable… Read More

For cancer researchers, understanding the intricacies of a cell is essential to treating patients and developing new therapies. Often this understanding is found through painstaking examination of a cell’s surface… Read More

When Dr. Sebastian Mikolajczak joined Seattle’s Center for Infectious Disease Research eleven years ago, he had a job to do: create a vaccine for malaria. Easier said than done. Although malaria… Read More

Despite a vibrant maker culture, and one of the top biotech industries in the nation, Seattle has never had a strong DIYbio community — a loose movement of amateur and professional scientists, working on creative… Read More

Seattle-based Nohla Therapeutics, a biotech startup spun out of the Fred Hutchinson Cancer Research Center, just announced a whopping $43.5 million Series A round, bringing the startup’s total funding to date… Read More

Seattle-based biotech company PhaseRx develops drug candidates to treat rare, often life-threatening liver diseases, and one of their candidates just got a boost from the FDA. The company’s leading drug, called… Read More

There are two basic models for scientific research — industry and academia — and each has its strengths. Academia can support sustained, long-term research. Industry is better at pushing the envelope with its entrepreneurial… Read More

The Seattle-based Infectious Disease Research Institute (IDRI), a product-focused nonprofit that fights infectious diseases around the world, announced today that it will receive $15 million from pharmaceutical giant Eli Lilly to… Read More

Back in 2009, immunotherapy was considered a long shot. The process involves reprogramming a patient’s T cells, important elements of the immune system, so that they attack cancerous cells. But since… Read More